Healthpeak Properties, Inc. (NYSE:DOC) Given Consensus Rating of "Moderate Buy" by Analysts

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) has received a consensus rating of "Moderate Buy" from the eleven research firms that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $23.45.

DOC has been the subject of several analyst reports. Robert W. Baird dropped their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Argus reaffirmed a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. StockNews.com cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Thursday, May 1st. Wedbush reduced their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Finally, Scotiabank decreased their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a report on Monday, May 12th.

Insider Buying and Selling

In other news, Director John T. Thomas acquired 4,200 shares of Healthpeak Properties stock in a transaction that occurred on Monday, April 28th. The shares were acquired at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the transaction, the director now directly owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. The trade was a 0.52% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Tommy G. Thompson bought 5,700 shares of the stock in a transaction on Friday, May 9th. The stock was purchased at an average cost of $17.36 per share, with a total value of $98,952.00. Following the acquisition, the director now owns 138,513 shares in the company, valued at approximately $2,404,585.68. This represents a 4.29% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 23,987 shares of company stock worth $422,141 in the last three months. 0.23% of the stock is owned by corporate insiders.

Institutional Trading of Healthpeak Properties

Several institutional investors have recently modified their holdings of the business. Parallel Advisors LLC grew its position in shares of Healthpeak Properties by 4.2% in the 1st quarter. Parallel Advisors LLC now owns 13,980 shares of the real estate investment trust's stock valued at $283,000 after buying an additional 561 shares during the last quarter. AdvisorNet Financial Inc lifted its stake in shares of Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust's stock worth $44,000 after acquiring an additional 563 shares during the period. Applied Finance Capital Management LLC boosted its holdings in Healthpeak Properties by 3.4% in the first quarter. Applied Finance Capital Management LLC now owns 17,648 shares of the real estate investment trust's stock valued at $357,000 after acquiring an additional 577 shares during the last quarter. Townsquare Capital LLC increased its position in Healthpeak Properties by 5.9% during the 4th quarter. Townsquare Capital LLC now owns 10,461 shares of the real estate investment trust's stock valued at $212,000 after purchasing an additional 584 shares during the period. Finally, Exchange Traded Concepts LLC increased its position in Healthpeak Properties by 10.0% during the 4th quarter. Exchange Traded Concepts LLC now owns 6,560 shares of the real estate investment trust's stock valued at $133,000 after purchasing an additional 598 shares during the period. Institutional investors own 93.57% of the company's stock.

Healthpeak Properties Price Performance

Shares of Healthpeak Properties stock opened at $17.72 on Friday. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $12.31 billion, a price-to-earnings ratio of 50.62, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. Healthpeak Properties has a twelve month low of $16.90 and a twelve month high of $23.26. The company has a 50-day simple moving average of $18.78 and a two-hundred day simple moving average of $20.06.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The business's revenue for the quarter was up 15.9% on a year-over-year basis. During the same period last year, the firm earned $0.45 earnings per share. Analysts forecast that Healthpeak Properties will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently declared a dividend, which will be paid on Friday, May 30th. Investors of record on Tuesday, May 20th will be issued a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend is Monday, May 19th. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.